Literature DB >> 31010399

Lupeol suppresses migration and invasion via p38/MAPK and PI3K/Akt signaling pathways in human osteosarcoma U-2 OS cells.

Ming-Jie Hsu1, Shu-Fen Peng1,2, Fu-Shin Chueh3, Chang-Hai Tsai4,5, Fuu-Jen Tsai4,6, Chih-Yang Huang7,8,9, Chih-Hsin Tang9,10,11, Jai-Sing Yang12, Yuan-Man Hsu1, Wen-Wen Huang1, Jing-Gung Chung1,9.   

Abstract

Lupeol, one of the common components from the fruits and natural foods, has been reported to exert antitumor activities in many human cancer cell lines; however, its effects on osteosarcoma cell metastasis were not elucidated. In the present study, lupeol at 10-25 μM induced cell morphological changes and decreased total viable cell number in U-2 OS cells. Lupeol (5-15 μM) suppressed cell mobility, migration, and invasion by wound healing and transwell chamber assays, respectively. Lupeol inhibited the activities of MMP-2 and -9 in U-2 OS cells by gelatin zymography assay. Lupeol significantly decreased PI3K, pAKT, β-catenin, and increased GSK3β. Furthermore, lupeol decreased the expressions of Ras, p-Raf-1, p-p38, and β-catenin. Lupeol also decreased uPA, MMP-2, MMP-9, and N-cadherin but increased VE-cadherin in U-2 OS cells. Based on these observations, we suggest that lupeol can be used in anti-metastasis of human osteosarcoma cells in the future.

Entities:  

Keywords:  Lupeol; human osteosarcoma U-2 OS cell; invasion; migration; p38 MAPK signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 31010399     DOI: 10.1080/09168451.2019.1606693

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

1.  Mg-based materials diminish tumor spreading and cancer metastases.

Authors:  Philipp Globig; Roshani Madurawala; Regine Willumeit-Römer; Fernanda Martini; Elisa Mazzoni; Bérengère J C Luthringer-Feyerabend
Journal:  Bioact Mater       Date:  2022-05-10

2.  Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer.

Authors:  Juan-Cheng Yang; Yang-Chang Wu; Yun-Hao Dai; Guan-Yu Chen; Chih-Hsin Tang; Wei-Chien Huang
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p.

Authors:  Jinghua Zhong; Chunlei He; Fangtian Xu; Xianyun Xu; Lulin Liu; Mingjun Xu; Zheng Guo; Yili Wang; Jiahua Liao; Yonghong Li
Journal:  J Orthop Surg Res       Date:  2020-09-03       Impact factor: 2.359

4.  LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p.

Authors:  Honghai Song; Jiaming Liu; Xin Wu; Yang Zhou; Xuanyin Chen; Jiangwei Chen; Keyu Deng; Chunxia Mao; Shanhu Huang; Zhili Liu
Journal:  Aging (Albany NY)       Date:  2019-11-13       Impact factor: 5.682

5.  Lupeol ameliorates LPS/D-GalN induced acute hepatic damage by suppressing inflammation and oxidative stress through TGFβ1-Nrf2 signal pathway.

Authors:  Sha Huang; Chan Mo; Ting Zeng; Yuqi Lai; Chuying Zhou; Shunwen Xie; Limei Chen; Yuhua Wang; Yuyao Chen; Shaohui Huang; Lei Gao; Zhiping Lv
Journal:  Aging (Albany NY)       Date:  2021-03-11       Impact factor: 5.682

6.  C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.

Authors:  Qianqian Qu; Zhongshun He; Yulei Jiang; Di Lu; Xiaolin Long; Yu Ding; Biao Xu; Xiaoqiong He
Journal:  Med Sci Monit       Date:  2019-10-07

7.  Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma.

Authors:  Jianwei Liu; Xiwen Liao; Xianze Zhu; Peizhen Lv; Rong Li
Journal:  Cancer Med       Date:  2020-08-11       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.